Hangzhou Bio-Sincerity Pharma-Tech Co Ltd - Class A

SZSE:301096 (China)   Class A
Â¥ 62.32 (-1.81%) May 24
23.52
P/B:
2.48
Market Cap:
Â¥ 6.79B ($ 937.30M)
Enterprise V:
Â¥ 6.76B ($ 933.16M)
Volume:
1.33M
Avg Vol (2M):
1.53M
Volume:
1.33M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Hangzhou Bio-Sincerity Pharma-Tech Co Ltd ( SZSE:301096 ) from 2021 to May 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hangzhou Bio-Sincerity Pharma-Tech stock (SZSE:301096) PE ratio as of May 24 2024 is 23.52. More Details

Hangzhou Bio-Sincerity Pharma-Tech Co Ltd (SZSE:301096) PE Ratio (TTM) Chart

To

Hangzhou Bio-Sincerity Pharma-Tech Co Ltd (SZSE:301096) PE Ratio (TTM) Historical Data

Total 587
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Hangzhou Bio-Sincerity Pharma-Tech PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-24 23.5 2024-03-15 28.7
2024-05-23 23.9 2024-03-14 28.4
2024-05-22 24.0 2024-03-13 28.1
2024-05-21 23.8 2024-03-12 27.8
2024-05-20 24.0 2024-03-11 27.5
2024-05-17 23.9 2024-03-08 26.4
2024-05-16 24.7 2024-03-07 26.3
2024-05-15 24.6 2024-03-06 26.9
2024-05-14 24.8 2024-03-05 27.0
2024-05-13 25.0 2024-03-04 27.6
2024-05-10 25.5 2024-03-01 27.0
2024-05-09 26.8 2024-02-29 26.7
2024-05-08 27.1 2024-02-28 26.2
2024-05-07 27.6 2024-02-27 26.9
2024-05-06 27.2 2024-02-26 26.5
2024-04-30 26.0 2024-02-23 26.4
2024-04-29 26.4 2024-02-22 26.8
2024-04-26 25.9 2024-02-21 26.9
2024-04-25 25.9 2024-02-20 26.3
2024-04-24 26.0 2024-02-19 25.9
2024-04-23 26.1 2024-02-08 26.3
2024-04-22 28.5 2024-02-07 24.0
2024-04-19 27.6 2024-02-06 23.6
2024-04-18 27.7 2024-02-05 21.8
2024-04-17 27.1 2024-02-02 22.5
2024-04-16 26.7 2024-02-01 24.1
2024-04-15 27.5 2024-01-31 23.6
2024-04-12 28.1 2024-01-30 25.2
2024-04-11 27.2 2024-01-29 26.2
2024-04-10 27.7 2024-01-26 26.8
2024-04-09 28.0 2024-01-25 27.8
2024-04-08 28.5 2024-01-24 26.5
2024-04-03 29.0 2024-01-23 26.6
2024-04-02 28.1 2024-01-22 26.4
2024-04-01 28.5 2024-01-19 27.8
2024-03-29 28.1 2024-01-18 27.8
2024-03-28 28.0 2024-01-17 27.8
2024-03-27 28.9 2024-01-16 28.4
2024-03-26 28.7 2024-01-15 27.4
2024-03-25 28.6 2024-01-12 27.4
2024-03-22 28.1 2024-01-11 27.5
2024-03-21 28.1 2024-01-10 26.7
2024-03-20 28.4 2024-01-09 27.0
2024-03-19 28.6 2024-01-08 27.0
2024-03-18 29.3 2024-01-05 27.5

Hangzhou Bio-Sincerity Pharma-Tech Co Ltd (SZSE:301096) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd is a pharmaceutical technology research and development company. The company's business covers drug discovery, pharmaceutical research, clinical research, and registration application.